Smoking is Associated with Increased Risk of Osteoporosis in Diabetes Mellitus Patients

Similar documents
Smoking is associated with osteoporosis development in Primary care population

OSTEOPOROSIS IN INDONESIA

LOVE YOUR BONES Protect your future

Using the FRAX Tool. Osteoporosis Definition

AGENDA. Risk factors for fracture in diabetes:

Objectives: What is Osteoporosis 10/8/2015. Bone Health/ Osteoporosis: BASICS OF SCREENING, INTERPRETING, AND TREATING

Bad to the Bones: Diabetes and Thiazolidinediones 9/9/2010. Steven Ing, MD, MSCE Assistant Professor Division of Endocrinology, Diabetes & Metabolism

Pharmacy Management Drug Policy

CLINICAL PROFILE OF TYPE 2 DIABETES

Osteoporosis Screening and Treatment in Type 2 Diabetes

Submission to the National Institute for Clinical Excellence on

9/5/2016. Faculty. Cardiometabolic Risk and Impact on Bone Health. Learning Objectives. Disclosures. Osteoporosis

Osteoporosis in Men. Until recently, the diagnosis of osteoporosis. A New Type of Patient. Al s case. How is the diagnosis made?

Study of secondary causes of male osteoporosis

Osteoporosis Knowledge Assessment among Medical Interns

AMERICAN COLLEGE OF RHEUMATOLOGY POSITION STATEMENT. Committee on Rheumatologic Care

IEHP UM Subcommittee Approved Authorization Guidelines DEXA Scan

Skeletal Manifestations

Bone Mineral Density and Its Associated Factors in Naresuan University Staff

Osteoporosis Clinical Guideline. Rheumatology January 2017

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm

The Center for Cancer Prevention and Treatment Public Reporting of Outcomes

JMSCR Vol 04 Issue 12 Page December 2016

Osteoporosis. Treatment of a Silently Developing Disease

International Journal of Scientific & Engineering Research Volume 8, Issue 7, July-2017 ISSN ,393

BMD: A Continuum of Risk WHO Bone Density Criteria

Building Bone Density-Research Issues

Helpful information about bone health & osteoporosis Patient Resource

Osteoporosis. Overview

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study

Pharmacy Management Drug Policy

Management of postmenopausal osteoporosis

Bone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome

Disclosures. Nutrition & Menopause. What changes? Mindless Eating 10/6/2017. I have no disclosures

Pharmacy Management Drug Policy

International Journal of Health Sciences and Research ISSN:

Coordinator of Post Professional Programs Texas Woman's University 1

Correlation between Thyroid Function and Bone Mineral Density in Elderly People

The Risk Factors and Prevention of Osteoporosis

Body Mass Index as Predictor of Bone Mineral Density in Postmenopausal Women in India

Bone. Disease. Cartilage. Strategies for Longevity. Joint Health

HIV and your Bones Osteopenia and Osteoporosis

Osteoporosis is a huge taboo once you pass a certain age, but it really doesn t have to be that way. Even though it is a serious, irreversible,

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

The Skeletal Response to Aging: There s No Bones About It!

DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN

Clinician s Guide to Prevention and Treatment of Osteoporosis

BREAST CANCER AND BONE HEALTH

Original article Pravara Med Rev 2010; 2(3)

Drug Intervals (Holidays) with Oral Bisphosphonates

Disclosure and Conflicts of Interest Steven T Harris MD Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis

BONE HEALTH Dr. Tia Lillie. Exercise, Physical Activity and Osteoporosis

The Relationship between Prevalence of Osteoporosis and Proportion of Daily Protein Intake

Osteoporosis/Fracture Prevention

THE THYROID. Your thyroid evaluation may include the following:

Practical Management Of Osteoporosis

Aromatase Inhibitors & Osteoporosis

Men and Osteoporosis So you think that it can t happen to you

Guideline for the investigation and management of osteoporosis. for hospitals and General Practice

BAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008

Bone health. Kirstie Stenhouse, NHS Forth #ACFALLS2018 #SPSP10

Diagnosis and management of osteoporosis

Fragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey

Breast Cancer and Bone Loss. One in seven women will develop breast cancer during a lifetime

1

A Study on Identification of Socioeconomic Variables Associated with Non-Communicable Diseases Among Bangladeshi Adults

Osteoporosis. When we talk about osteoporosis, we have to be familiar with the constituents of bone and what it is formed of.

DISCLAIMER DO NOT DISTRIBUTE

COPD-Related Musculoskeletal Disease. Jessica Bon Field, MD, MS 2017 Update in Internal Medicine October 20, 2017

Relationship between Bone Mineral Density and Maturity Index in Cervical Smears, Serum Estradiol Levels and Body Mass Index

Download slides:

Australian Journal of Basic and Applied Sciences

9/26/2016. The Impact of Dietary Protein on the Musculoskeletal System. Research in dietary protein, musculoskeletal health and calcium economy

Use of DXA / Bone Density in the Care of Your Patients. Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist

Meta-analysis: analysis:

Autonomic neuropathy

MEASURE. MANAGE. MOTIVATE. bodyandbone MOBILE LAB DEXA BODY COMPOSITION SCAN RESTING METABOLIC RATE TEST DEXA BONE MINERAL DENSITY TEST

JOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 7, August 2014

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

Hemoglobin. What is it? Why is iron important? What food sources contain iron?

Bone mineral density of patients attending a clinic in Dubai

Discovering prior fractures in your postmenopausal patient may be the LINK to reducing her fragility fracture* risk in the future.

Osteoporosis: fragility fracture risk. Costing report. Implementing NICE guidance

Bone Densitometry Pathway

Knowledge, Attitudes, Practices and Behaviour on Non-Communicable Diseases, Kosovo Qamile Ramadani, Elvira Rasimi, Ariana Bytyci

Endocrine Regulation of Calcium and Phosphate Metabolism

Bone Mass Measurement BONE MASS MEASUREMENT HS-042. Policy Number: HS-042. Original Effective Date: 8/25/2008

Chapter 39: Exercise prescription in those with osteoporosis

Forteo (teriparatide) Prior Authorization Program Summary

Osteoporosis as a Focus for Practice Improvement

Concordance of a Self Assessment Tool and Measurement of Bone Mineral Density in Identifying the Risk of Osteoporosis in Elderly Taiwanese Women

International Journal of Research and Review E-ISSN: ; P-ISSN:

RISK FACTORS FOR OSTEOPOROSIS IN POST-MENOPAUSAL WOMEN WITH HIP FRACTURES

Awareness and knowledge of a silent

Osteoporosis. Current Trend in Osteoporosis Management for Elderly in HK- Medical Perspective. Old Definition of Osteoporosis

Osteoporosis challenges

OSTEOPOROSIS: PREVENTION AND MANAGEMENT

Bone Densitometry. What is a Bone Density Scan (DXA)? What are some common uses of the procedure?

Transcription:

Research Article imedpub Journals http://www.imedpub.com DOI: 10.4172/2469-6684.100031 Smoking is Associated with Increased Risk of Osteoporosis in Diabetes Mellitus Patients Tahir Alsaadawi Hilla Teaching Hospital, Hilla, Babylon, Iraq Abstract Background: Diabetes mellitus, in particular Type 2 Diabetes Mellitus (T2DM), is a common metabolic disease with increasing prevalence throughout the world. Musculoskeletal (MSK) complications of DM are the most common endocrine arthropathies. Osteoporosis is considered a global public health problem currently affecting over than 200 million people. Osteoporosis is the most common systemic skeleton illness that characterized by reduce of bone mass and disruption of bone architecture resulting an increased risk of fragility fractures which represent the main clinical consequence of the disease. Smoking is associated with multiple complications of diabetes; the risk of complications associated with tobacco use and diabetes in combination has been stated to be approximately 14 times higher than the risk of either smoking or diabetes alone. Objective: To assess the association of smoking with osteoporosis in diabetes mellitus patients. Patients and Methods: A cross sectional study was conducted on 150 patients with diabetes mellitus mainly type 2. All patients were seen in the Department of Rheumatology in Hilla Teaching Hospital. Patient s data were obtained via face-toface interview performed by a rheumatologist. DM related data, such as duration, Smoking history, drug use (oral hypoglycaemic drugs, insulin), Body Mass Index (BMI), patient send for DEXA (Dual Energy X-ray Absorptiometry) to confirm diagnosis of osteoporosis, also after exclusion of other causes of osteoporosis by exclusion criteria which done by many hormonal and other laboratory investigations. Results: Among 150 patients with DM, 60.70% were females and 39.30% were males, as the females predominant in the study. There is an association between osteoporosis and age <50 years (p<0.004) due to most patients were female at premenopausal age. There is significant association between smoking and osteoporosis in DM patients (p<0.002), Also, BMI show no significant association with osteoporosis in DM patients as most of patients were obese or overweight with increase bone mineral density. Conclusion: There is significant association between smoking and osteoporosis in DM patients. Keywords: Diabetes mellitus; Arthropathies; Osteoporosis, Rheumatology, Bone mineral density, Musculoskeletal Corresponding author: Tahir Alsaadawi tahiralsaadawi@yahoo.com Hilla Teaching Hospital, Hilla, Babylon, Iraq. Citation: Alsaadawi T. Smoking is Associated with Increased Risk of Osteoporosis in Diabetes Mellitus Patients. J Bone Rep Recommendations., 2:4. Received: October 16, ; Accepted: October 17, ; Published: October 30, Under License of Creative Commons Attribution 3.0 License This article is available in: http://bone.imedpub.com/ 1

Introduction Diabetes mellitus Diabetes mellitus, in particular Type 2 Diabetes Mellitus (T2DM), is a common metabolic disease with increasing prevalence throughout the world [1]. Musculoskeletal (MSK) complications of DM are the most common endocrine arthropathies. These have been generally under- recognized and poorly treated compared with other complications, such as neuropathy, retinopathy, and nephropathy. These manifestations, which are some of the causes of chronic disability, involve not only the joints, but also the bones and the soft tissues [2]. Chronic complications adversely affect multiple organ systems, including bones, and cause an enormous medical and economic burden [3]. Typical skeletal complications of poorly controlled diabetes mellitus include diabetic foot syndrome and Charcot neuro-arthropathy, which account for a high percentage of surgical procedures and even amputations. Fragility fractures owing to low bone strength have become increasingly recognized, as skeletal complications [4]. Osteoporosis Osteoporosis is considered a global public health problem currently affecting over than 200 million people [5]. In particular, 1 in 3 women over 50 years old will experience osteoporotic fractures in contrast with 1 in 5 men [6]. Evidently, the overall prevalence of osteoporosis is higher in females approaching 80% [7]. Osteoporosis is the most common systemic skeleton illness that characterized by reduce of bone mass and disruption of bone architecture resulting an increased risk of fragility fractures which represent the main clinical consequence of the disease. It is often called the silent disease because the loss of bone occurs silently and progressively and there are no symptoms until the first fracture appear [8]. The World Health Organization (WHO) recommended that females are much more likely to develop osteoporosis that gradually increased with age [9]. Furthermore, low dietary calcium and lifestyle (smoking and alcohol consumption) have also been associated for an increased risk for osteoporosis, especially tobacco use as recently reported for the Greek citizens with 40% proportion [10]. Smoking Smokers were defined as tobacco users of >30 packs per year (20 cigarettes/pack) following the WHO recommendations [11]. Smoking is associated with multiple complications of diabetes; the risk of complications associated with tobacco use and diabetes in combination has been stated to be approximately 14 times higher than the risk of either smoking or diabetes alone [12]. Smoking is thought to cause low bone density through various pathways 1. Smoking has been linked to changes in hormone household, leading to a decrease in parathyroid hormone (thus reducing calcium absorption) and estrogen levels as well as to an increase in the level of cortisol and adrenal androgens, changes that have been linked to an increased risk of osteoporosis [13]. 2. Smoking reduces body mass, which is postulated to provide an estrogenic stimulus and is linked to higher BMD [14]. 3. Smoking reduces the level of vitamin D in the body, which is required for good bone health [15]. 4. Smoking increases free radicals and oxidative stress which affects bone desorption [16]. 5. Smokers are more likely to suffer from peripheral vascular disease, reducing blood supply to the bones [17]. 6. Finally, there may also exist direct toxic effects of many of the constituents in tobacco smoke on bone cells [18]. Patients and Methods Study population A cross sectional study was conducted on 150 patients with diabetes mellitus mainly type 2. All patients were seen in the Department of Rheumatology in Hilla Teaching Hospital, a tertiary referral centre in Iraq between June 2014 and June 2015. The study was granted full ethical approval from the local ethics committee and all patients gave their informed written consent prior to commencement of the study. Diabetes mellitus characteristics Patient s data were obtained via face-to-face interview performed by a rheumatologist. DM related data, such as duration, Smoking history, drug use (oral hypoglycaemic drugs, insulin), Body Mass Index (BMI), patient send for DEXA (Dual Energy X-ray Absorptiometry) to confirm diagnosis of osteoporosis, also after exclusion of other causes of osteoporosis by exclusion criteria which done by many hormonal and other laboratory investigations. Exclusion criteria 1) Menopause 2) Corticosteroid therapy 3) Low body weight (BMI <I8) 4) Alcohol 5) Connective tissue diseases e.g., RA, SLE, AS, etc 6) Thyroid problems 7) Parathyroid problems 8) Hypo-gonadism 2 This article is available in: http://bone.imedpub.com/

JA 9) Celiac disease 10) Drugs: Thyroxin, Corticosteroids, Cyclosporine, Heparin, Anticonvulsants, Gonadotropin-releasing hormones, Aromatase inhibitors and Cyto-toxic drugs 11) Family history Statistical analysis Statistical Package for Social Sciences version 18 (SPSS v.18) was used for data input and analysis. Discrete variables presented as numbers and percentages. Continuous variables presented as mean and Standard Deviation (SD). χ 2 Test for goodness of fit used to test the significance of observed distributions. χ 2 Test for independence used to test the significance of association between two discrete variables. To test the significance of difference in mean for more than one sample; ANOVA test used for normally distributed variables and Kruskal-Willis test used when the distribution was in question. p Value used for all tests was asymptotic and two sided. Findings with p value less than 0.05 considered significant. Results The overall mean age of DM patients was (55.46 ± 8.58) years, and (77.3%) of patients were 50 years and older, and ( 22.7%) less than 50 years (Figure 1). This figure shows that majority of DM patients were females (60.7%), and (39.3%) were males (Figure 2). Table 1 shows the distribution of DM patients by BMI and smoking habit. (58.7%) and (58.0%) of DM patients were with normal weight and non-smokers, respectively. This table shows that (52.7%) of DM patients had the disease less than 5 years and (98.7%) were on OHA (Table 2). Figure 3 shows that (74.7%) of DM patients did not have Osteoporosis and (25.6%) had osteoporosis. There was significant between presence of osteoporosis and age groups, p value 0.004 is significant (Table 3). There was significant between presence of osteoporosis and Smoking Habit, p value 0.002 is significant (Table 4). Discussion According to the results of this study, there is significant association between osteoporosis and age <50 years, the explanation of that is the majority of patients were females and premenopausal age. In this study, there is significant association between smoking habits (current smoker) and osteoporosis in diabetes mellitus patients with (p<0.002), this in agreement with other studies done by Kao WHL, et al. Barrette-Connor, et al. and Schwartz AV, et al. [19,20,21], that the T2DM tend to be higher BMI or over weight, increased insulin level, less physical activity and smoke more. Figure 1 Figure 2 Figure 3 77.30% 22.70% <50 years 50years Age of diabetes mellitus patients. The overall mean age of DM patients was (55.46 ± 8.58) years, and (77.3 %) of patients were 50 years and older. 60.70% 39.30% Shows the distribution of DM patients by sex. 74.70% 25.60% Osteoporosis Male Female Non-Osteoporosis Shows the distribution of DM patients by presence of osteoporosis (74.7%) of DM patients did not have osteoporosis. Under License of Creative Commons Attribution 3.0 License 3

BMI shows no significant association with osteoporosis and this in agreement with other studies done by Wang, et al. and Barrera, et al. [22,23] that show no relation of BMI to osteoporosis, the possible explanation of that most T2DM were obese or overweight with increased bone mineral density. The main limitation of our sturdy was the small size of studied samples and being cross-sectional sturdy, has limited the correlation regarding the cause and effect relationship between smoking and osteoporosis in DM patients. Conclusion There is significant association between smoking and osteoporosis in diabetes mellitus patients. Recommendations 1) Proper attention to the diabetes mellitus patients who were smokers, to decrease risk of osteoporosis in those patients. 2) Musculoskeletal complication especially osteoporosis in DM were underestimated which considered as part of chronic disability. 3) The finding in this study will need to be confirmed using large prospective study. Table 1 Shows the distribution of DM patients by BMI and smoking habit. (58.7%) and (58.0%) of DM patients were with normal weight and non-smokers, respectively. Variable Frequency (%) BMI Normal weight 88 (58.7) Obese 62 (41.3) Smoking habit Smokers 63 (42.0) Non-Smokers 87 (58.0) Table 2 Shows the distribution of DM patients by duration of disease and type of treatment. (52.7%) and (98.7%) of DM patients had the disease less than 5 years and were on OHA, respectively. Variable Frequency (%) Duration of disease <5years 79 (52.7) 5years 71 (47.3) Type of treatment Insulin 2 (1.3) OHA 148 (98.7) Table 3 Shows the Association of Osteoporosis with DM patients Socio- Demographic Characteristics. There was significant between presence of osteoporosis and age groups, p value are significant. Osteoporosis χ 2 p Variable Absent (%) Present (%) Values Age groups <50 years 19 (17.0) 15 (39.5) 8.201 0.004* 50years 93 (83.0) 23 (60.5) Sex Male 49 (43.8) 10 (26.3) 3.614 0.057 Female 63 (56.2) 28 (73.7) Residence Urban area 50 (44.6) 17 (44.7) 0.000 0.992 Rural area 62 (55.4) 21 (55.3) Table 4 Shows the Association of osteoporosis with DM patients BMI and smoking Habit. There was significant between presence of osteoporosis and smoking Habit, p value is significant. Osteoporosis χ 2 p Variable Absent (%) Present (%) Values BMI Normal weight 66 (58.9) 22 (57.9) 0.013 0.911 Obese 46 (41.1) 16 (42.1) Smoking habit Smokers 39 (34.8) 24 (63.2) 9.352 0.002* Non-Smokers 73 (65.2) 14 (36.8) 4 This article is available in: http://bone.imedpub.com/

JA References 1 Hamann C, Kirschner S, Gunther KP (2012) Bone, sweet boneosteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol 8: 297-305. 2 Attar SM (2012) Musculoskeletal manifestations in diabetic patients at a tertiary center. Libyan J Med 7: 19162. 3 Loughlin OA, Mclntosh C, Dinneen SF, Brien OT (2010) Review paper: basic concepts to novel therapies: a review of the diabetic foot. Int J Low Extrem Wounds 9: 90-l02. 4 Vestergaard P, Rejnmark L, Mosekilde L (2009) Diabetes and its complications and their relationship with risk of fractures in type I and 2 diabetes. Calcif Tissue Int 84: 45-55. 5 International Osteoporosis foundation (2014) Osteoporosis and muskuloskeletal disorders- what is Osteoporosis? Eipidemiology. 6 International Osteoporosis Foundation (2014) DATA &PUBLICATIONS - Facts and Statistics. 7 Lane JM, Serota AC, Raphael B (2006) Osteoporosis: Differences and Similarities in Male and female Patients. Orthop Clin North Am 37: 4601-609. 8 Kleisiaris F, Plaiti E, Papathanasiou V (2015) Smoking is associated with osteoporosis development in Primary care population, Amer Journ of Nurs Scien 4(2-1): 96-101. 9 World Health Organization (2003) Prevention and management of osteoporosis: report of a WHO scientific group. Geneva. 10 Eurobarometer S. Attitudes of Europeans towards tobacco (2007) TNS Opinion Social. 11 International Osteoporosis Foundation (2014) Osteoporosis and musculoskletal disorders- osteoporosis- who's at risk- one minute Osteoporosis risk test. 12 Haire-Joshu D, Thomas J (2005) Gambling with addiction: Dangerous beliefs about smoking and diabetes. Diabet Voi Smok and diabet 50: 15-18. 13 Kapoor D, Jones TH (2005) Smoking and hormones in health and endocrine disorders. Eur J Endocrinol 152: 491-499. 14 Daniel M, Martin AD, Drinkwater DT (1992) Cigarette smoking, steroid hormones, and bone mineral density in young women. Calcif Tissue Int 50: 300-305. 15 Brot C, Jorgensen NR, Sorensen OH (1990) The influence of smoking on vitamin D status and calcium metabolism. Euro J Clin Nutr 53: 920-926. 16 Duthie GG, Arthur JR, James WP (1991) Effects of smoking and vitamin D on blood antioxidant status. Am J Clin Nutr 53: 1061-1063. 17 Vestergaard P, Mosekilde L (2003) Fracture risk associated with smoking: a meta-analysis. J Intern Med 254: 572-583. 18 Broulik PD, Jarab J (1993) The effect of chronic nicotine administration on bone mineral content in mice. Horm Metab Res 25: 219-221. 19 Kao WHL, Kammerer CM, Schneider JL, Bauer RL, Mitchell BD (2003) Type 2 diabetes is associated with increased bone mineral density in Mexican-American women. Arch Med Res 34: 399-406. 20 Barrett-Connor E, Holbrook TL (1992) Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. JAMA. 268: 3333-3337. 21 Schwartz AV, Sellmeyer DE, Ensrud T (2001) Study of Osteoporotic features Research Group. Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86: 32-38. 22 Wang M, Bachrach L, Van Loan M, Hudes M, Flegal K, et al. (2005) Thc relative contributions of lean tissue mass and fat mass to bone density in young women. Bone 37: 474-481. 23 Barrera G, Bunout D, Gattas V, Leiva L, Hirsch S (2004) A high body mass index protects against femoral neck osteoporosis in healthy elderly subjects. Nutrition 20: 769-771. Under License of Creative Commons Attribution 3.0 License 5